Author:
Gay Marina,Sánchez-Jiménez Ester,Villarreal Laura,Vilanova Mar,Huguet Romain,Arauz-Garofalo Gianluca,Díaz-Lobo Mireia,López-Ferrer Daniel,Vilaseca Marta
Reference48 articles.
1. Vialaret J, Schmit PO, Lehmann S, Gabelle A, Wood J, Bern M, Paape R, Suckau D, Kruppa G, Hirtz C (2018) Identification of multiple proteoforms biomarkers on clinical samples by routine Top-Down approaches. Data Brief 18:1013–1021
2. Smith LM, Kelleher NL, Consortium for Top Down P (2013) Proteoform: a single term describing protein complexity. Nat Methods 10(3):186–187
3. Aebersold R, Agar JN, Amster IJ, Baker MS, Bertozzi CR, Boja ES, Costello CE, Cravatt BF, Fenselau C, Garcia BA, Ge Y, Gunawardena J, Hendrickson RC, Hergenrother PJ, Huber CG, Ivanov AR, Jensen ON, Jewett MC, Kelleher NL, Kiessling LL, Krogan NJ, Larsen MR, Loo JA, Ogorzalek Loo RR, Lundberg E, MacCoss MJ, Mallick P, Mootha VK, Mrksich M, Muir TW, Patrie SM, Pesavento JJ, Pitteri SJ, Rodriguez H, Saghatelian A, Sandoval W, Schluter H, Sechi S, Slavoff SA, Smith LM, Snyder MP, Thomas PM, Uhlen M, Van Eyk JE, Vidal M, Walt DR, White FM, Williams ER, Wohlschlager T, Wysocki VH, Yates NA, Young NL, Zhang B (2018) How many human proteoforms are there? Nat Chem Biol 14(3):206–214
4. Sea L (2016) Profiling of intact proteins in the CSF of Alzheimer’s disease patients using top down clinical proteomics (TDCP): a new approach giving access to isoform specific information of neurodegenerative biomarkers. Alzheimers Dement 12(7):183–184
5. Cabras T, Pisano E, Montaldo C, Giuca MR, Iavarone F, Zampino G, Castagnola M, Messana I (2013) Significant modifications of the salivary proteome potentially associated with complications of Down syndrome revealed by top-down proteomics. Mol Cell Proteomics 12(7):1844–1852